21.0692.03000 HOUSE BILL NO. 1213 with Conference Committee Amendments Sixty-seventh Legislative Assembly HOUSE BILL NO. 1213 of North Dakota Introduced by Representatives Westlind, Dobervich, Hanson, M. Ruby, Skroch Senator K. Roers 1 A BILL for an Act to create and enact section 19-24.1-04.1 of the North Dakota Century Code, 2 relating to medical marijuana designated caregivers; to amend and reenact section 19-03.1-01, 3 subsection 5 of section 19-03.1-05, subsection 1 of section 19-03.1-22.2, section 19-03.1-22.3, 4 subsections 1, 7, and 9 of section 19-03.1-23, subsection 12 of section 19-03.4-01, sections 5 19-03.4-03, 19-03.4-04, and 19-24.1-01, subdivision a of subsection 2 of section 19-24.1-03, 6 subsection 3 of section 19-24.1-04, sections 19-24.1-10 and 19-24.1-13, paragraph 2 of 7 subdivision d of subsection 1 of section 19-24.1-14, subdivision a of subsection 1 of section 8 19-24.1-15, subdivision a of subsection 2 of section 19-24.1-16, section 19-24.1-17, 9 subsection 4 of section 19-24.1-18, subsection 2 of section 19-24.1-20, subsection 3 of section 10 19-24.1-26, subsection 2 of section 19-24.1-37, section 19-24.1-39, and subsection 1 of section 11 39-20-01 of the North Dakota Century Code, relating to the medical marijuana program; to 12 provide for a legislative management report; to provide a penalty; and to declare an emergency. 13 BE IT ENACTED BY THE LEGISLATIVE ASSEMBLY OF NORTH DAKOTA: 14 SECTION 1. AMENDMENT. Section 19-03.1-01 of the North Dakota Century Code is 15 amended and reenacted as follows: 16 19-03.1-01. Definitions. 17 As used in this chapter and in chapters 19-03.2 and 19-03.4, unless the context otherwise 18 requires: 19 1. "Administer" means to apply a controlled substance, whether by injection, inhalation, 20 ingestion, or any other means, directly to the body of a patient or research subject by: 21 a. A practitioner or, in the practitioner's presence, by the practitioner's authorized 22 agent; or 23 b. The patient or research subject at the direction and in the presence of the 24 practitioner. Page No. 1 21.0692.03000 Sixty-seventh Legislative Assembly 1 2. "Agent" means an authorized person who acts on behalf of or at the direction of a 2 manufacturer, distributor, or dispenser. It does not include a common or contract 3 carrier, public warehouseman, or employee of the carrier or warehouseman. 4 3. "Anabolic steroids" means any drug or hormonal substance, chemically and 5 pharmacologically related to testosterone, other than estrogens, progestins, and 6 corticosteroids. 7 4. "Board" means the state board of pharmacy. 8 5. "Bureau" means the drug enforcement administration in the United States department 9 of justice or its successor agency. 10 6. "Controlled substance" means a drug, substance, or immediate precursor in schedules 11 I through V as set out in this chapter. 12 7. "Controlled substance analog": 13 a. Means a substance the chemical structure of which is substantially similar to the 14 chemical structure of a controlled substance in a schedule I or II and: 15 (1) Which has a stimulant, depressant, or hallucinogenic effect on the central 16 nervous system which is substantially similar to or greater than the 17 stimulant, depressant, or hallucinogenic effect on the central nervous 18 system of a controlled substance in schedule I or II; or 19 (2) With respect to a particular individual, which the individual represents or 20 intends to have a stimulant, depressant, or hallucinogenic effect on the 21 central nervous system substantially similar to or greater than the stimulant, 22 depressant, or hallucinogenic effect on the central nervous system of a 23 controlled substance in schedule I or II. 24 b. Does not include: 25 (1) A controlled substance; 26 (2) Any substance for which there is an approved new drug application; or 27 (3) With respect to a particular individual, any substance, if an exemption is in 28 effect for investigational use, for that individual, under section 505 of the 29 Federal Food, Drug, and Cosmetic Act [21 U.S.C. 355] to the extent conduct 30 with respect to the substance is pursuant to the exemption. Page No. 2 21.0692.03000 Sixty-seventh Legislative Assembly 1 8. "Counterfeit substance" means a controlled substance which, or the container or 2 labeling of which, without authorization, bears the trademark, trade name, or other 3 identifying mark, imprint, number or device, or any likeness thereof, of a manufacturer, 4 distributor, or dispenser other than the person who in fact manufactured, distributed, or 5 dispensed the substance. 6 9. "Deliver" or "delivery" means the actual, constructive, or attempted transfer from one 7 person to another of a controlled substance whether or not there is an agency 8 relationship. 9 10. "Dispense" means to deliver a controlled substance to an ultimate user or research 10 subject by or pursuant to the lawful order of a practitioner, including the prescribing, 11 administering, packaging, labeling, or compounding necessary to prepare the 12 substance for that delivery. 13 11. "Dispenser" means a practitioner who dispenses. 14 12. "Distribute" means to deliver other than by administering or dispensing a controlled 15 substance. 16 13. "Distributor" means a person who distributes. 17 14. "Drug" means: 18 a. Substances recognized as drugs in the official United States pharmacopeia 19 national formulary, or the official homeopathic pharmacopeia of the United States, 20 or any supplement to any of them; 21 b. Substances intended for use in the diagnosis, cure, mitigation, treatment, or 22 prevention of disease in individuals or animals; 23 c. Substances, other than food, intended to affect the structure or any function of 24 the body of individuals or animals; and 25 d. Substances intended for use as a component of any article specified in 26 subdivision a, b, or c. The term does not include devices or their components, 27 parts, or accessories. 28 15. "Hashish" means the resin extracted from any part of the plant cannabis with or 29 without its adhering plant parts, whether growing or not, and every compound, 30 manufacture, salt, derivative, mixture, or preparation of the resin. 31 16. "Immediate precursor" means a substance: Page No. 3 21.0692.03000 Sixty-seventh Legislative Assembly 1 a. That the board has found to be and by rule designates as being the principal 2 compound commonly used or produced primarily for use in the manufacture of a 3 controlled substance; 4 b. That is an immediate chemical intermediary used or likely to be used in the 5 manufacture of the controlled substance; and 6 c. The control of which is necessary to prevent, curtail, or limit the manufacture of 7 the controlled substance. 8 17.16. "Manufacture" means the production, preparation, propagation, compounding, 9 conversion, or processing of a controlled substance, either directly or indirectly by 10 extraction from substances of natural origin, or independently by means of chemical 11 synthesis, or by a combination of extraction and chemical synthesis and includes any 12 packaging or repackaging of the substance or labeling or relabeling of its container. 13 The term does not include the preparation or compounding of a controlled substance 14 by an individual for the individual's own use or the preparation, compounding, 15 packaging, or labeling of a controlled substance: 16 a. By a practitioner as an incident to the practitioner's administering or dispensing of 17 a controlled substance in the course of the practitioner's professional practice; or 18 b. By a practitioner, or by the practitioner's authorized agent under the practitioner's 19 supervision, for the purpose of, or as an incident to, research, teaching, or 20 chemical analysis and not for sale. 21 18.17. "Marijuana" means all parts of the plant of the genus cannabis sativa L., whether 22 growing or not; the seeds thereof; the resin extracted from any part of the plant; and 23 every compound, manufacture, salt, derivative, mixture, or preparation of the plant, its 24 seeds, or resin. The term does not include the: 25 a. The tetrahydrocannabinol extracted or isolated from the plant; 26 b. The mature stalks of the plant, fiber produced from the stalks, oil or cake made 27 from the seeds of the plant, any other compound, manufacture, salt, derivative, 28 mixture, or preparation of mature stalks, except the resin extracted therefrom, 29 fiber, oil, or cake, or the sterilized seed of the plant which is incapable of 30 germination. The term marijuana does not include hemp as defined in title 4.1.; 31 c. Hemp as defined in chapter 4.1 - 18.1; or Page No. 4 21.0692.03000 Sixty-seventh Legislative Assembly 1 d. A prescription drug approved by the United States food and drug administration 2 under section 505 of the Federal Food, Drug, and Cosmetic Act [21 U.S.C. 355]. 3 19.18. "Narcotic drug" means any of the following, whether produced directly or indirectly by 4 extraction from substances of vegetable origin, or independently by means of chemical 5 synthesis, or by a combination of extraction and chemical synthesis: 6 a. Opium and opiate and any salt, compound, derivative, or preparation of opium or 7 opiate. 8 b. Any salt, compound, isomer, derivative, or preparation thereof which is 9 chemically equivalent or identical with any of the substances referred to in 10 subdivision a, but not including the isoquinoline alkaloids of opium.